Rapid Micro Biosystems Inc (RPID) is an innovative biotechnology company focused on revolutionizing microbiological quality control processes within the pharmaceutical and biotechnology industries. Utilizing state-of-the-art automated growth-based microbial detection technologies, RPID significantly improves the accuracy and efficiency of microbial testing, which is vital for adhering to stringent regulatory standards. As demand for rapid and reliable quality assurance solutions continues to grow, Rapid Micro is well-positioned to drive advancements in testing methodologies that are essential for maintaining product safety and excellence in highly regulated environments.
| Revenue (TTM) | $34.38M |
| Gross Profit (TTM) | $1.01M |
| EBITDA | $-46.89M |
| Operating Margin | -173.10% |
| Return on Equity | -116.70% |
| Return on Assets | -41.90% |
| Revenue/Share (TTM) | $0.76 |
| Book Value | $0.45 |
| Price-to-Book | 5.06 |
| Price-to-Sales (TTM) | 2.97 |
| EV/Revenue | 3.022 |
| EV/EBITDA | 0.82 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 11.10% |
| Shares Outstanding | $45.32M |
| Float | $27.21M |
| % Insiders | 9.90% |
| % Institutions | 54.21% |
Volatility is currently expanding